Background A 56-year-old white woman was referred to our institution with a 16-month history of severe, gouty, recurrent, acute polyarthritis involving the finger joints. She also had numerous small ...

Researchers have identified a new therapeutic target for the treatment of gout, a common type of arthritis that causes episodes of painful and stiff joints. Their study suggests that blocking a ...

Gout is the most common type of inflammatory arthritis in the world and is caused by the buildup of uric acid crystals in your joints. These crystals form when there’s too much uric acid in your blood ...

Please provide your email address to receive an email when new articles are posted on . When an individual has an excess of uric acid in the blood, it can crystallize in the joints and cause gout, the ...

Credit: Getty Images. Ilaris is an interleukin-1β blocker. The Food and Drug Administration (FDA) has approved Ilaris ® (canakinumab) for the symptomatic treatment of adult patients with gout flares ...

T he word gout may make you think of overweight Victorian-era royalty with overly rich diets. But this common form of inflammatory arthritis, which leads to pain and swelling in one or more ...

Gout is an intensely painful form of arthritis that affects over 8 million Americans. As our diets change to include more processed foods, and with the increase in popularity of high protein diets, ...

Please provide your email address to receive an email when new articles are posted on . The FDA has approved Ilaris for the treatment of gout flares in adults, marking it as the first biologic therapy ...

An Arrowhead Pharmaceuticals “gene-silencing” drug that the biotech has been quietly researching as a gout treatment will continue its development under a partnership with Horizon Therapeutics.

Gout is a type of inflammatory arthritis caused by high levels of uric acid in your body. Although the pain of gout most commonly occurs in the big toe, it may also occur in other areas, such as your ...

Patients with gout and type 2 diabetes treated with SGLT2 inhibitors not only had reduced numbers of gout flares, but also lived longer compared with other such patients receiving other medications, ...

Get the latest news on coronavirus and more delivered daily to your inbox. Sign up here. A team of researchers in New York is pairing with another group in Montreal to explore whether a common ...